Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-07-08
2008-07-08
McGarry, Sean (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A, C536S024310, C536S024330
Reexamination Certificate
active
10496945
ABSTRACT:
A pharmaceutical composition comprises the sequence of SEQ ID NO:s 3-5 or pharmaceutically equivalent sequences. Methods employing the pharmaceutical compositions include treatments to increase angiogenesis, to stimulate HIF-1α function, to treat hypoxia-related conditions, and to maintain normal cell functions under hypoxia.
REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5998148 (1999-12-01), Bennett et al.
patent: 2002/0165140 (2002-11-01), Berkenstam et al.
patent: 98/03517 (1998-12-01), None
patent: 98/25314 (1999-06-01), None
patent: 98/25753 (1999-06-01), None
patent: 99/18539 (2000-02-01), None
patent: 00/15325 (2000-12-01), None
patent: WO 00/78341 (2000-12-01), None
patent: 01/01334 (2001-08-01), None
patent: 01/01387 (2002-01-01), None
American Psychological Association (APA): composition. (n.d.). The American Heritage® Dictionary of the English Language, Fourth Edition. Retrieved Jun. 7, 2007, from Dictionary.com website: http://dictionary.reference.com/browse/composition.
Agrawal 2000, Antisense therapeutics: is it as simple as complementary base recognition? Mol. Med. Today, vol. 61, 72-81.
Jen et al. Suppresion of Gene Expression by Targeted Disruption of Messenger RNA: Available Options and Current Strategies. Stem Cells (2000), vol. 18:307-319. AlphaMed Press.
Opalinska et al. 2002 Nucleic-acid therapeutics: basic principles and recent applications. Nature Reviews, vol. 1, pp. 503-514).
Gradin et al, Functional Interference between Hypoxia and Dioxin Signal Transduction Pathways: Competition for Recruitment of the Arnt Transcription Factor, Molecular and Cell Biology, vol. 16, No. 10, Oct. 1996, pp. 5221-5231.
Accession No. AI322407; Oct. 20, 1998.
Makino Yuichi
Poellinger Lorenz
AngioGenetics Sweden AB
Chong Kimberly
Garabedian Todd E.
McGarry Sean
Wiggin and Dana LLP
LandOfFree
Regulation of hypoxia-inducible gene expression with... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of hypoxia-inducible gene expression with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of hypoxia-inducible gene expression with... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3919927